{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T10:49:01Z","timestamp":1772794141183,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81471558"],"award-info":[{"award-number":["81471558"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.biopha.2018.07.021","type":"journal-article","created":{"date-parts":[[2018,7,12]],"date-time":"2018-07-12T01:37:36Z","timestamp":1531359456000},"page":"813-820","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Study on the efficacy and mechanism of triptolide on treating TNF transgenic mice with rheumatoid arthritis"],"prefix":"10.1016","volume":"106","author":[{"given":"Shengli","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuguang","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhigang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinying","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenqiang","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7880-6328","authenticated-orcid":false,"given":"Xinchun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2018.07.021_bib0005","doi-asserted-by":"crossref","first-page":"12","DOI":"10.2133\/dmpk.DMPK-13-RV-119","article-title":"Molecular basis for pharmacokinetics and pharmacodynamics of methotrexate in rheumatoid arthritis therapy","volume":"29","author":"Inoue","year":"2014","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.biopha.2018.07.021_bib0010","doi-asserted-by":"crossref","first-page":"955","DOI":"10.2217\/imt.13.94","article-title":"Current immunotherapy in rheumatoid arthritis","volume":"5","author":"Meier","year":"2013","journal-title":"Immunother.-UK"},{"issue":"433","key":"10.1016\/j.biopha.2018.07.021_bib0015","first-page":"404","article-title":"Traditional immunosuppression\u2014Lei Gong Teng in modern medicine","volume":"152","author":"Caspi","year":"2013","journal-title":"Harefuah"},{"key":"10.1016\/j.biopha.2018.07.021_bib0020","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.canlet.2010.10.025","article-title":"Molecular targets of celastrol derived from thunder of god vine: potential role in the treatment of inflammatory disorders and cancer","volume":"303","author":"Kannaiyan","year":"2011","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biopha.2018.07.021_bib0025","doi-asserted-by":"crossref","first-page":"229","DOI":"10.7326\/0003-4819-151-4-200908180-00005","article-title":"Comparison of Tripterygium wilfordii Hook F versus sulfasalazine in the treatment of rheumatoid arthritis: a randomized trial","volume":"151","author":"Goldbach-Mansky","year":"2009","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.biopha.2018.07.021_bib0030","doi-asserted-by":"crossref","DOI":"10.1002\/pmic.201700001","article-title":"Quantitative proteomics and targeted fatty acids analysis reveal the damage of triptolide in liver and kidney","volume":"17","author":"Li","year":"2017","journal-title":"Proteomics"},{"key":"10.1016\/j.biopha.2018.07.021_bib0035","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.phymed.2015.06.007","article-title":"Activation of the farnesoid X receptor attenuates triptolide-induced liver toxicity","volume":"22","author":"Jin","year":"2015","journal-title":"Phytomedicine"},{"key":"10.1016\/j.biopha.2018.07.021_bib0040","doi-asserted-by":"crossref","first-page":"4025","DOI":"10.1002\/j.1460-2075.1991.tb04978.x","article-title":"Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis","volume":"10","author":"Keffer","year":"1991","journal-title":"EMBO J."},{"issue":"8","key":"10.1016\/j.biopha.2018.07.021_bib0045","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1002\/art.27503","article-title":"Evaluation of therapeutic targets in animal models of arthritis: how does it relate to rheumatoid arthritis?","volume":"62","author":"Bevaart","year":"2010","journal-title":"Arthritis Rheumatol."},{"issue":"8","key":"10.1016\/j.biopha.2018.07.021_bib0050","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1002\/art.40125","article-title":"Tumor necrosis factor\u2013transgenic mice: close enough to human epigenetics?","volume":"69","author":"M\u00fcller-Ladner","year":"2017","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.biopha.2018.07.021_bib0055","first-page":"626038","article-title":"Triptolide prevents bone destruction in the collagen-induced arthritis model of rheumatoid arthritis by targeting RANKL\/RANK\/OPG signal pathway","volume":"2013","author":"Liu","year":"2013","journal-title":"Evid. Complement. Altern. Med."},{"key":"10.1016\/j.biopha.2018.07.021_bib0060","doi-asserted-by":"crossref","first-page":"e77513","DOI":"10.1371\/journal.pone.0077513","article-title":"Anti-angiogenic effect of triptolide in rheumatoid arthritis by targeting angiogenic cascade","volume":"8","author":"Kong","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2018.07.021_bib0065","article-title":"Compatibility with Panax notoginseng and Rehmannia glutinosa alleviates the hepatotoxicity and nephrotoxicity of Tripterygium wilfordii via modulating the pharmacokinetics of triptolide","volume":"19","author":"Zhang","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2018.07.021_bib0070","first-page":"2663","article-title":"Fabrication of novel vesicles of triptolide for antirheumatoid activity with reduced toxicity in vitro and in vivo","volume":"11","author":"Zhang","year":"2016","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biopha.2018.07.021_bib0075","doi-asserted-by":"crossref","first-page":"402","DOI":"10.3389\/fphar.2016.00402","article-title":"Safety profiles of Tripterygium wilfordii Hook F: a systematic review and meta-analysis","volume":"7","author":"Zhang","year":"2016","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2018.07.021_bib0080","doi-asserted-by":"crossref","first-page":"385352","DOI":"10.1155\/2014\/385352","article-title":"TNFalpha promotes Th17 cell differentiation through IL-6 and IL-1beta produced by monocytes in rheumatoid arthritis","volume":"2014","author":"Zheng","year":"2014","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.biopha.2018.07.021_bib0085","doi-asserted-by":"crossref","first-page":"12950","DOI":"10.18632\/oncotarget.2633","article-title":"LIGHT\/TNFSF14 increases osteoclastogenesis and decreases osteoblastogenesis in multiple myeloma-bone disease","volume":"5","author":"Brunetti","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2018.07.021_bib0090","doi-asserted-by":"crossref","first-page":"R187","DOI":"10.1186\/ar4018","article-title":"Atorvastatin inhibits osteoclastogenesis by decreasing the expression of RANKL in the synoviocytes of rheumatoid arthritis","volume":"14","author":"Kim","year":"2012","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.biopha.2018.07.021_bib0095","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1002\/ar.22479","article-title":"Effect of triptolide on T-cell receptor beta variable gene mRNA expression in rats with collagen-induced arthritis","volume":"295","author":"Wang","year":"2012","journal-title":"Anat. Rec. (Hoboken)"},{"key":"10.1016\/j.biopha.2018.07.021_bib0100","doi-asserted-by":"crossref","first-page":"8048170","DOI":"10.1155\/2016\/8048170","article-title":"Triptolide inhibits osteoclast differentiation and bone resorption in vitro via enhancing the production of IL-10 and TGF-beta1 by regulatory t cells","volume":"2016","author":"Xu","year":"2016","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.biopha.2018.07.021_bib0105","doi-asserted-by":"crossref","first-page":"9148523","DOI":"10.1155\/2017\/9148523","article-title":"Tripterygium wilfordii glycosides upregulate the new anti-inflammatory cytokine IL-37 through ERK1\/2 and p38 MAPK signal pathways","volume":"2017","author":"Wang","year":"2017","journal-title":"Evid. Complement. Altern. Med."},{"key":"10.1016\/j.biopha.2018.07.021_bib0110","first-page":"4111","article-title":"Triptolide protects bone against destruction by targeting RANKL-mediated ERK\/AKT signalling pathway in the collagen-induced rheumatoid arthritis","volume":"28","author":"Gong","year":"2017","journal-title":"Biomed. Res.-India"},{"key":"10.1016\/j.biopha.2018.07.021_bib0115","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1002\/jcb.25191","article-title":"Correlating RANK ligand\/RANK binding kinetics with osteoclast formation and function","volume":"116","author":"Warren","year":"2015","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.biopha.2018.07.021_bib0120","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.biochi.2014.07.003","article-title":"Triptolide, a diterpene, inhibits osteoclastogenesis, induced by RANKL signaling and human cancer cells","volume":"105","author":"Park","year":"2014","journal-title":"Biochimie"},{"key":"10.1016\/j.biopha.2018.07.021_bib0125","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/jbmr.559","article-title":"RANK-dependent autosomal recessive osteopetrosis: characterization of five new cases with novel mutations","volume":"27","author":"Pangrazio","year":"2012","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.biopha.2018.07.021_bib0130","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.mce.2014.10.016","article-title":"Triptolide inhibits osteoclast formation, bone resorption, RANKL-mediated NF-B activation and titanium particle-induced osteolysis in a mouse model","volume":"399","author":"Huang","year":"2015","journal-title":"Mol. Cell. Endocrinol."}],"updated-by":[{"DOI":"10.1016\/j.biopha.2018.09.027","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000}}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218324612?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218324612?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T19:32:16Z","timestamp":1750879936000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332218324612"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":26,"alternative-id":["S0753332218324612"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2018.07.021","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Study on the efficacy and mechanism of triptolide on treating TNF transgenic mice with rheumatoid arthritis","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2018.07.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}